PROPHYLACTIC USE OF CARVEDILOL TO PREVENT VENTRICULAR DYSFUNCTION IN PATIENTS WITH CANCER TREATED WITH DOXORUBICIN

被引：0
|
作者：
Kinsara, Abdulhalim [1 ]
Abuosa, Ahmed [1 ]
Elsheikh, Ayman [1 ]
Qureshi, Kahekashan [1 ]
Abrar, Mohammed [1 ]
Kholeif, Mona [1 ]
Andejani, Abdulwahab [1 ]
Ahmed, Adel [1 ]
Cleland, John [2 ]
机构：
[1] King Saud bin Abdulaziz Univ Hlth Sci, COMJ King Abdul Aziz Med City WR King, Jeddah, Saudi Arabia
[2] Imperial Coll, Natl Heart & Lung Inst, Royal Brompton & Harefield Hosp, London, England
来源：
HEART | 2018年 / 104卷
关键词：
D O I：
10.1136/heartjnl-2018-BCS.90
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
91
引用
收藏
页码：A76 / A76
页数：1
相关论文
共 50 条
  • [31] Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin
    Lee, Seon-Hwa
    Cho, Iksung
    You, Seng-Chan
    Cha, Min-Jae
    Chang, Jee-Suk
    Kim, William D.
    Go, Kyu-yong
    Kim, Dae-Young
    Seo, Jiwon
    Shim, Chi-Young
    Hong, Geu-Ru
    Kang, Seok-Min
    Ha, Jong-Won
    Rha, Sun-Young
    Kim, Hyo-Song
    CANCERS, 2022, 14 (09)
  • [32] A subgroup analysis on mortality and nonfatal reinfarction in patients with left ventricular dysfunction or heart failure after AMI treated with carvedilol in the CAPRICORN study
    Scherhag, A
    Lopez-Sendon, JL
    Dargie, HJ
    Remme, WJ
    Sharpe, N
    Colucci, WS
    Ford, I
    CIRCULATION, 2002, 106 (19) : 612 - 612
  • [33] Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both
    Bonaca, Marc P.
    Moslehi, Javid J.
    Ledermann, Jonathan A.
    Michelon, Elisabete
    Wei, Caimiao
    Moran, Michael
    Monk, Bradley J.
    Pujade-Lauraine, Eric
    ONCOLOGIST, 2023, 28 (10): : e977 - e980
  • [34] Efficacy of prophylactic use of haloperidol to prevent delirium in critically ill patients
    Santos, A.
    Soares, P.
    Costa, R.
    Marques, D.
    De Eca, B.
    Neves, I.
    Calmon Londero, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 595 - 595
  • [35] Key Issues in Use of Prophylactic Steroids to Prevent Hypocalcemia and Voice Dysfunction After Thyroidectomy Reply
    Dhahri, Adeel Abbas
    Rao, Ahsan
    Ahmad, Raheel
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (05) : 493 - 494
  • [36] Carvedilol reduces mortality, recurrent events in patients with post-MI left ventricular dysfunction
    不详
    FORMULARY, 2001, 36 (05) : 377 - 377
  • [37] Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation
    Pamboukian, SV
    Aminbakhsh, A
    Thompson, CR
    Amin, H
    Mortimer, S
    D'yachkova, Y
    Ignaszewski, AP
    CLINICAL TRANSPLANTATION, 1999, 13 (05) : 426 - 431
  • [38] The Effect of Enalapril and Carvedilol on Left Ventricular Dysfunction in Middle Childhood and Adolescent Patients With Muscular Dystrophy
    Kwon, Hye Won
    Kwon, Bo Sang
    Kim, Gi Beom
    Chae, Jong Hee
    Park, June Dong
    Bae, Eun Jung
    Noh, Chung Il
    KOREAN CIRCULATION JOURNAL, 2012, 42 (03) : 184 - 191
  • [39] Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy
    Conway, Kristin M.
    Thomas, Shiny
    Ciafaloni, Emma
    Khan, Rabia S.
    Mann, Joshua R.
    Romitti, Paul A.
    Mathews, Katherine D.
    BIRTH DEFECTS RESEARCH, 2024, 116 (01):
  • [40] Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
    Guglin, Maya
    Krischer, Jeffrey
    Tamura, Roy
    Fink, Angelina
    Bello-Matricaria, Lauren
    McCaskill-Stevens, Worta
    Munster, Pamela N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (22) : 2859 - 2868
12345